Work

Sapanisertib and serabelisib (PIKTOR) with paclitaxel and a diet substudy in patients with advanced/recurrent endometrial cancer (GOG-3111).

Year: 2025

Type: article

Study design: Study Protocol

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps5633

Authors: David Starks, Joyce N. Barlin, Maria M. Rubinstein, Debbie Chirnomas, Jennifer Drescher, Oliver D. K. Maddocks, Farzana Walcott, Juan Jelf, Ramez Nassef Eskander, Amanda Lynn Jackson, Brian M. Slomovitz

Institutions: Avera Health, Albany Medical College, Memorial Sloan Kettering Cancer Center, Moores Cancer Center, University of Cincinnati, Mount Sinai Medical Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410820755

FWCI:

Cites:

Cited by:

Related to: 10